Search research articles
Contact Us
Filters
Showing results (731-740 of 797) with videos related to
Page
of 80
Sort By:
Circulation Research
|
March 16, 2018
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study
Ali J Marian, Yanli Tan, Lili Li, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 22, 2000
Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor
P Zoldhelyi, P J Beck, R J Bjercke, et al.
Circulation Research
|
July 8, 2015
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure
Emerson C Perin, Kenneth M Borow, Guilherme V Silva, et al.
Journal of the American College of Cardiology
|
October 19, 2004
Task force 2: Investigator participation in clinical research
Robert M Califf, Steven E Nissen, Anthony N DeMaria, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2012
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors
Jose Francisco Islas, Yu Liu, Kuo-Chan Weng, et al.
The American Journal of Cardiology
|
November 27, 2007
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein
Paul M Ridker, Francisco A H Fonseca, Jacques Genest, et al.
Lancet (London, England)
|
March 31, 2009
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M Ridker, Eleanor Danielson, Francisco Ah Fonseca, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 13, 2007
Five common gene variants identify elevated genetic risk for coronary heart disease
Lance A Bare, Alanna C Morrison, Charles M Rowland, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)
Paul M Ridker, Jean G MacFadyen, Francisco A H Fonseca, et al.
The Journal of Biological Chemistry
|
May 25, 2013
Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion
Peter Vanderslice, Ronald J Biediger, Darren G Woodside, et al.
Page
of 80
Search research articles
Search
Showing results (731-740 of 797) with videos related to
Sort By:
Page
of 80
Circulation Research
|
March 16, 2018
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study
Ali J Marian, Yanli Tan, Lili Li, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 22, 2000
Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor
P Zoldhelyi, P J Beck, R J Bjercke, et al.
Circulation Research
|
July 8, 2015
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure
Emerson C Perin, Kenneth M Borow, Guilherme V Silva, et al.
Journal of the American College of Cardiology
|
October 19, 2004
Task force 2: Investigator participation in clinical research
Robert M Califf, Steven E Nissen, Anthony N DeMaria, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2012
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors
Jose Francisco Islas, Yu Liu, Kuo-Chan Weng, et al.
The American Journal of Cardiology
|
November 27, 2007
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein
Paul M Ridker, Francisco A H Fonseca, Jacques Genest, et al.
Lancet (London, England)
|
March 31, 2009
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M Ridker, Eleanor Danielson, Francisco Ah Fonseca, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 13, 2007
Five common gene variants identify elevated genetic risk for coronary heart disease
Lance A Bare, Alanna C Morrison, Charles M Rowland, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)
Paul M Ridker, Jean G MacFadyen, Francisco A H Fonseca, et al.
The Journal of Biological Chemistry
|
May 25, 2013
Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion
Peter Vanderslice, Ronald J Biediger, Darren G Woodside, et al.
Page
of 80